347 related articles for article (PubMed ID: 1313717)
1. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris.
Bourlond A; Lachapelle JM; Aussems J; Boyden B; Campaert H; Conincx S; Decroix J; Geeraerts C; Ghekiere L; Morias J
Int J Dermatol; 1989; 28(6):410-2. PubMed ID: 2548967
[TBL] [Abstract][Full Text] [Related]
3. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
Panagiotidou D; Kousidou T; Chaidemenos G; Karakatsanis G; Kalogeropoulou A; Teknetzis A; Chatzopoulou E; Michailidis D
J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
[TBL] [Abstract][Full Text] [Related]
5. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
Wishart JM
N Z Med J; 1994 Apr; 107(975):126-8. PubMed ID: 8145958
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Van Hecke E; Van Cutsem J
Mycoses; 1988 Dec; 31(12):641-9. PubMed ID: 2852776
[No Abstract] [Full Text] [Related]
7. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
Faergemann J; Mörk NJ; Haglund A; Odegård T
Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules.
Saul A; Bonifaz A
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):554-8. PubMed ID: 2170473
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages.
Degreef H; Mariën K; De Veylder H; Duprez K; Borghys A; Verhoeve L
Rev Infect Dis; 1987; 9 Suppl 1():S104-8. PubMed ID: 3027832
[TBL] [Abstract][Full Text] [Related]
10. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
Voravutinon V
J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
[TBL] [Abstract][Full Text] [Related]
12. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Goh CL; Tay YK; Ali KB; Koh MT; Seow CS
Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole in the treatment of tinea corporis and tinea cruris: comparison of two treatment schedules.
Boonk W; de Geer D; de Kreek E; Remme J; van Huystee B
Mycoses; 1998 Dec; 41(11-12):509-14. PubMed ID: 9919895
[TBL] [Abstract][Full Text] [Related]
15. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Singh S; Chandra U; Anchan VN; Verma P; Tilak R
Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
17. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
Lebwohl M; Elewski B; Eisen D; Savin RC
Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
[TBL] [Abstract][Full Text] [Related]
19. Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review.
De Doncker P; Cauwenbergh G
Br J Clin Pract Suppl; 1990 Sep; 71():118-22. PubMed ID: 1965415
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris.
Parent D; Decroix J; Heenen M
Dermatology; 1994; 189(4):378-81. PubMed ID: 7873824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
